Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Osteoporosis affects both men and women, but women face higher risks due to biological differences, menopause, and pregnancy.

Bisphosphonates are the mainstay of osteoporosis therapy. Extensive clinical evaluation supports their utility in stemming progression of the disease and in reducing fracture risk. In the course ...

A new study found that levothyroxine, a common medication for hypothyroidism sold as Synthroid, is linked to bone loss in ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Millions of postmenopausal women find themselves facing a diagnosis of osteoporosis, but what does that mean for their daily ...

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

known as osteoporosis, which makes them frail and vulnerable to falls. But the researchers from John Hopkins University said adults of all ages taking the drug should discuss the risks with their ...

Professor Lee Jung-ryul's team at Bundang Seoul National University Hospital (Professor Lee Kang-won, Dr. Choong-mo Yang, and ...

I had no clue that someone my age could suffer from osteoporosis, or develop a fracture simply from running, but that’s what happened. The first inkling that something was wrong came when I was ...